J.P. Morgan analyst Sterling Auty downgraded Medidata Solutions (MDSO) to Sell today. The company’s shares closed yesterday at $73.85.
According to TipRanks.com, Auty is a 5-star analyst with an average return of 12.1% and a 58.7% success rate. Auty covers the Technology sector, focusing on stocks such as SolarWinds Corporation, Altair Engineering Inc, and Ellie Mae Inc.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Medidata Solutions with a $85.80 average price target.
See today’s analyst top recommended stocks >>
Medidata Solutions’ market cap is currently $4.52B and has a P/E ratio of 87.92. The company has a Price to Book ratio of 7.61.
Based on the recent corporate insider activity of 57 insiders, corporate insider sentiment is negative on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Medidata Solutions, Inc. provides cloud based solutions for life sciences for customer’s clinical development processes including concept, conclusion, research optimization, and development investments. Its cloud-based technology including its unified platform, pioneering analytics, and clinical technology allows the development of new therapies pharmaceutical companies, biotech, and medical device firms, academic medical centers and contract research organizations around the world. It operates through the following geographical segments: United States, Japan, and Other. The company was founded by Glen M. de Vries, Edward F. Ikeguchi and Tarek A. Sherif in June 1999 and is headquartered in New York, NY.
